1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient demographics and clinical characteristics
UK (n = 72) RT (n = 125) Age (mean ± SD), yr 58 ± 15 61 ± 13 Male 36 (50.0) 67 (53.6) Female 36 (50.0) 58 (46.4) Hypertension 43 (59.7) 78 (62.4) Diabetes mellitus 14 (19.4) 20 (16.0) Coronary artery disease 13 (18.0) 33 (26.4) Atrial fibrillation 14 (19.4) 29 (23.2) Tobacco use 11 (15.3) 26 (20.8) Blood glucose (mean ± SD), mg/dl 149.4 ± 55 134.0 ± 51 Presentation NIHSS median (range) 16 (3–27) 18 (2–39) Prior IV rtPA treatment (n = 182) 65 (90.3) 117 (93.6)
Note:—Values in parentheses are percentages, except for Presentation NIHSS median.